Form4.ai tracks every SEC insider trade in real time. See every MNPR insider filing with a free account — no card.
See every MNPR insider filing — free account, no card.
Free accountMonopar Therapeutics (MNPR) has 9 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Oct. 20, 2026.
Open-market value, last 90 days
No open-market buys or sales in this period.
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 20, 2026 SEC filing | Robinson Chandler Chief Executive Officer | Tax withholding | $55,276 | — |
| Oct 5, 2026 SEC filing | STARR CHRISTOPHER M Director | Cashless exercise | $659,345 | — |
| Oct 2, 2026 SEC filing | Cittadine Andrew Chief Operating Officer | Vest & sell-to-cover | +2,440 sh | — |
Create a free account to see all 9 MNPR filings from the last 90 days. No card needed.
Create free accountWant MNPR insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.